Malaria elimination: Surveillance and response

Pathogens and Global Health

Volumn 106, Issue 4, 2012, Pages 224-231

  Bridges, Daniel J ^a   Winters, Anna M ^a   Hamer, Davidson H ^b,c,d  

^a Akros Research   (Zambia)

^b Zambia Centre for Applied Health Research and Development   (Zambia)

^c BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^d BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Active case detection; Elimination; Malaria; Plasmodium falciparum; Sub saharan africa; Surveillance; Zambia

Indexed keywords

ARTEMISININ; CHLORPHENOTANE; PRIMAQUINE;

COMMUNITY CARE; DISEASE CARRIER; DISEASE SURVEILLANCE; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; GAMETOCYTE; HEMOLYSIS; HUMAN; INCIDENCE; INSECTICIDE RESISTANCE; MALARIA; MALARIA CONTROL; MOBILE PHONE; MORTALITY; MOSQUITO; PARASITEMIA; POLYMERASE CHAIN REACTION; PREVALENCE; REVIEW; SEASON; VECTOR CONTROL;

COMMUNICABLE DISEASE CONTROL; DISEASE ERADICATION; EPIDEMIOLOGICAL MONITORING; HUMANS; MALARIA; WORLD HEALTH;

EID: 84875289613     PISSN: 20477724     EISSN: 20477732     Source Type: Journal    
DOI: 10.1179/2047773212Y.0000000035     Document Type: Review

References (59)

1. World Health Organization. World Malaria Report. 2011. Available from: http://www.who.int/malaria/world_malaria_report_2010/en/index.html
2. Murray CJL, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet. 2012;379(9814):413-31.
3. O'Meara WP, Mangeni JN, Steketee R, Greenwood B. Changes in the burden of malaria in sub-Saharan Africa. Lancet Infect Dis. 2010;10(8):545-55.
4. Dondorp AM, Nosten FO, Yi P, Das D, Phyo AP, Tarning J, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2009;361(5):455-67.
5. Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE. Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Clin Infect Dis. 2011;53(3):224-30.
6. Hamer DH, Ndhlovu M, Zurovac D, Fox M, Yeboah-Antwi K, Chanda P, et al. Improved diagnostic testing and malaria treatment practices in Zambia. JAMA. 2007;297(20):2227-31.
7. Kelly-Hope L, Ranson H, Hemingway J. Lessons from the past: managing insecticide resistance in malaria control and eradication programmes. Lancet Infect Dis. 2008;8(6):387-9.
8. Sabot O, Cohen JM, Hsiang MS, Kahn JG, Basu S, Tang L, et al. Costs and financial feasibility of malaria elimination. Lancet. 2010;376(9752):1604-15.
9. Snow RW, Marsh K. Malaria in Africa: progress and prospects in the decade since the Abuja Declaration. Lancet. 2010;376(9735):137-9.
10. Cohen JM, Moonen B, Snow RW, Smith DL. How absolute is zero? An evaluation of historical and current definitions of malaria elimination. Malar J. 2010;9:213.
11. World Health Organization.Malaria elimination-a field manual for low and moderate endemic countries. 2007. Available from: http://www.rbm.who.int/toolbox/tool_EliminationManualWHO.html
12. Feachem RGA, Phillips AA, Hwang J, Cotter C, Wielgosz B, Greenwood BM, et al. Shrinking the malaria map: progress and prospects. Lancet. 2010;376(9752):1566-78.
13. Na ́ jera JA, Gonzalez-Silva M, Alonso PL. Some lessons for the future from the Global Malaria Eradication Programme (1955- 1969). PLoS Med. 2011;8(1):e1000412.
14. Yekutiel P. Problems of epidemiology in malaria eradication. Bull World Health Organ. 1960;22:669-83.
15. Livadas GA, Georgopoulos G. Development of resistance to DDT by Anopheles sacharovi in Greece. Bull World Health Organ. 1953;8(4):497-511.
16. Spielman A, Kitron U, Pollack RJ. Time limitation and the role of research in the worldwide attempt to eradicate malaria. J Med Entomol. 1993;30(1):6-19.
17. Hall BF, Fauci AS. Malaria control, elimination, and eradication: the role of the evolving biomedical research agenda. J Infect Dis. 2009;200(11):1639-43.
18. Roll Back Malaria. The Global Malaria Action Plan. 2008. Available from: http://www.rbm.who.int/gmap/index.html
19. Woolhouse ME, Dye C, Etard JF, Smith T, Charlwood JD, Garnett GP, et al. Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci USA. 1997;94(1):338-42.
20. Zambian Ministry of Health. National Malaria Control Action Plan. 2011. Available from: http://www.nmcc.org.zm/files/NATIONALMALARIACONTROLACTIONPLAN2011-200611.pdf
21. malERA Consultative Group on Monitoring, Evaluation, and Surveillance, Steketee R, Voltaire F, Hay SI, Alonso PL, Atta HY, et al. A research agenda for malaria eradication: monitoring, evaluation, and surveillance. PLoS Med. 2011;8(1):e1000400.
22. Alves FP, Durlacher RR, Menezes MJ, Krieger H, Silva LHP, Camargo EP. High prevalence of asymptomatic Plasmodium vivax and Plasmodium falciparum infections in native Amazonian populations. Am J Trop Med Hyg. 2002;66(6):641-8.
23. WHO. Disease Surveillance for Malaria Elimination - An Operational Manual. Geneva: WHO; 2012.
24. German RR, Lee LM, Horan JM, Milstein RL, Pertowski CA, Waller MN, et al. Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR Recomm Rep. 2001;50(RR-13):1-35.
25. Campbell CC, Steketee RW. Malaria in Africa can be eliminated. Am J Trop Med Hyg. 2011;85(4):584-5.
26. Ogutu B, Tiono AB, Makanga M, Premji Z, Gbadoe ́ AD, Ubben D, et al. Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria? Malar J. 2010;9:30.
27. Chen W. The malaria eradication programme in Taiwan: annual report for the year 1959. Taipei: Taiwan Provincial Malaria Research Institute; 1959.
28. Macauley C. Aggressive active case detection: a malaria control strategy based on the Brazilian model. Soc Sci Med. 2005;60(3):563-73.
29. Greenwood BM. Control to elimination: implications for malaria research. Trends Parasitol. 2008;24(10):449-54.
30. Chanda P, Hamainza B, Mulenga S, Chalwe V, Msiska C, Chizema-Kawesha E. Early results of integrated malaria control and implications for the management of fever in under-five children at a peripheral health facility: a case study of Chongwe rural health centre in Zambia. Malar J. 2009;8:49.
31. Yeboah-Antwi K, Pilingana P, Macleod WB, Semrau K, Siazeele K, Kalesha P, et al. Community case management of fever due to malaria and pneumonia in children under five in Zambia: a cluster randomized controlled trial. PLoS Med. 2010;7(9):e1000340.
32. Chanda P, Hamainza B, Moonga HB, Chalwe V, Pagnoni F. Community case management of malaria using ACT and RDT in two districts in Zambia: achieving high adherence to test results using community health workers. Malar J. 2011;10:158.
33. Seidenberg PD, Hamer DH, Iyer H, Pilingana P, Siazeele K, Hamainza B, et al. Impact of integrated community case management on health seeking behavior in rural Zambia. Am J Trop Med Hyg. 2012;(Under Review).
34. McMorrow ML, Aidoo M, Kachur SP. Malaria rapid diagnostic tests in elimination settings-can they find the last parasite? Clin Microbiol Infect. 2011;17(11):1624-31.
35. Stresman GH, Kamanga A, Moono P, Hamapumbu H, Mharakurwa S, Kobayashi T, et al. A method of active case detection to target reservoirs of asymptomatic malaria and gametocyte carriers in a rural area in Southern Province, Zambia. Malar J. 2010;9:265.
36. World Health Organization. Guidelines for the treatment of malaria. 2010. Available from: http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf
37. malERA Consultative Group on Integration Strategies. A research agenda for malaria eradication: cross-cutting issues for eradication. PLoS Med. 2011;8(1):e1000404.
38. World Health Organization. Parasitological confirmation of malaria diagnosis. 2009. Available from: http://whqlibdoc.who.int/publications/2010/9789241599412_eng.pdf
39. malERA Consultative Group on Diagnoses and Diagnostics, Alonso PL, Barnwell JW, Bell D, Hanson K, Mendis K, et al. A research agenda for malaria eradication: diagnoses and diagnostics. PLoS Med. 2011;8(1):e1000396.
40. Notomi T, Okayama H, Masubuchi H, Yonekawa T, Watanabe K, Amino N, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res. 2000;28(12):E63.
41. Mabunda S, Aponte JJ, Tiago A, Alonso P. A country-wide malaria survey in Mozambique. II. Malaria attributable proportion of fever and establishment of malaria case definition in children across different epidemiological settings. Malar J. 2009;8:74.
42. Stepniewska K, Price RN, Sutherland CJ, Drakeley CJ, von Seidlein L, Nosten F, et al. Plasmodium falciparum gametocyte dynamics in areas of different malaria endemicity. Malar J. 2008;7:249.
43. Kappe SH, Vaughan AM, Boddey JA, Cowman AF. That was then but this is now: malaria research in the time of an eradication agenda. Science. 2010;328:862-6.
44. Bousema T, Okell L, Shekalaghe S, Griffin JT, Omar S, Sawa P, et al. Revisiting the circulation time of Plasmodium falciparum gametocytes: molecular detection methods to estimate the duration of gametocyte carriage and the effect of gametocytocidal drugs. Malar J. 2010;9:136.
45. malERA Consultative Group on Drugs, Alonso PL, Djimde A, Kremsner P, Magill A, Milman J, et al. A research agenda for malaria eradication: drugs. PLoS Med. 2011;8(1):e1000402.
46. Schneider P, Bousema JT, Gouagna LC, Otieno S, van de Vegte-Bolmer M, Omar SA, et al. Submicroscopic Plasmodium falciparum gametocyte densities frequently result in mosquito infection. Am J Trop Med Hyg. 2007;76(3):470-4.
47. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, et al. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med. 2008;359(24):2619-20.
48. Newton PN, Green MD, Mildenhall DC, Planc ̧on A, Nettey H, Nyadong L, et al. Poor quality vital anti-malarials in Africa - an urgent neglected public health priority. Malar J. 2011;10:352.
49. Asidi A, N'guessan R, Akogbeto M, Curtis C, Rowland M. Loss of household protection from use of insecticide-treated nets against pyrethroid-resistant mosquitoes, Benin. Emerg Infect Dis. 2012;18(7):1101-6.
50. malERA Consultative Group on Vector Control, Alonso PL, Besansky NJ, Burkot TR, Collins FH, Hemingway J, et al. A research agenda for malaria eradication: vector control. PLoS Med. 2011;8(1):e1000401.
51. World Health Organization. WHO Policy recommendation on Intermittent Preventive Treatment during infancy with sulphadoxine- pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa. World Malaria Report 2009. Geneva, Switzerland, WHO, 2010.
52. Worrall E, Fillinger U. Large-scale use of mosquito larval source management for malaria control in Africa: a cost analysis. Malar J. 2011;10:338.
53. malERA Consultative Group on Vaccines,Alonso PL, Ballou R, Brown G, Chitnis C, Loucq C, et al. A research agenda for malaria eradication: vaccines. PLoS Med. 2011;8(1): e1000398.
54. Buy, cell, hold. Economist. 25-1-2007. Available from http://www.economist.com/node/8597377
55. The world in 2010: ICT facts and figures. International Telecommunication Union. 2010. Available from: www.itu.int/ITU-D/ict/material/FactsFigures2010.pdf
56. Kamanga A, Moono P, Stresman G, Mharakurwa S, Shiff C. Rural health centres, communities and malaria case detection in Zambia using mobile telephones: a means to detect potential reservoirs of infection in unstable transmission conditions. Malar J. 2010;9:96.
57. Malaria Control and Evaluation Partnership in Africa. Rapid reporting systems: tracking data to defeat malaria. 2011. Available from: http://www.path.org/files/MACEPA_rapidreporting_101411.pdf
58. Zurovac D, Sudoi RK, Akhwale WS, Ndiritu M, Hamer DH, Rowe AK, et al. The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial. Lancet. 2011;378(9793):795-803.
59. Moonen B, Cohen JM, Snow RW, Slutsker L, Drakeley C, Smith DL, et al. Operational strategies to achieve and maintain malaria elimination. Lancet. 2010;376(9752):1592-603.